QA: Celularity Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001752828_2023_Celularity_Inc.pdf

Logs

warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 0.8220122894285834, 'aggregate_val': 43588000, 'exp_sum': 23923000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 66021000, 'ResearchAndDevelopmentExpense': 78363000, 'remainder_Expenses': -120461000}}

Graph

Absolute values for 0001752828, Celularity Inc

  xvar xval
0 AssetsCurrent 33,502,000
1 IntangibleAssetsNetIncludingGoodwill 240,688,000
2 PropertyPlantAndEquipmentNet 75,655,000
3 remainder_Assets 51,221,000
4 LiabilitiesCurrent 62,088,000
5 LiabilitiesNoncurrent 30,525,000
6 remainder_Liabilities 109,552,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 66,021,000
9 ResearchAndDevelopmentExpense 78,363,000
10 remainder_Expenses -100,796,000
11 remainder_Revenues 17,975,000
12 remainder_NetIncome 39,805,000
13 remainder_ComprehensiveNetIncome 9,000
  yvar yval
0 Assets 401,066,000
1 Liabilities 202,165,000
2 Expenses 43,588,000
3 Revenues 17,975,000
4 StockholdersEquity 198,901,000
5 NetIncome 14,192,000
6 ComprehensiveNetIncome 14,196,500
7 BaseVar 352,304,000
8 EconomicCapitalRatio 1.18

Edgar->Model Mapping

Feature Distribution

Change over Time